Cargando…
A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus
Severe acute respiratory syndrome (SARS) is a serious infectious disease caused by the SARS coronavirus. We assessed the potential of prime-boost vaccination protocols based on the nucleocapsid (NC) protein co-administered with a derivative of the mucosal adjuvant MALP-2 or expressed by modified Vac...
Autores principales: | Schulze, Kai, Staib, Caroline, Schätzl, Hermann M., Ebensen, Thomas, Erfle, Volker, Guzman, Carlos A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115531/ https://www.ncbi.nlm.nih.gov/pubmed/18805454 http://dx.doi.org/10.1016/j.vaccine.2008.09.006 |
Ejemplares similares
-
Cell Type-Specific Cleavage of Nucleocapsid Protein by Effector Caspases during SARS Coronavirus Infection
por: Diemer, Claudia, et al.
Publicado: (2008) -
Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi
por: Sanchez Alberti, Andrés, et al.
Publicado: (2020) -
Modular organization of SARS coronavirus nucleocapsid protein
por: Chang, Chung-ke, et al.
Publicado: (2005) -
Analysis of multimerization of the SARS coronavirus nucleocapsid protein
por: He, Runtao, et al.
Publicado: (2004) -
The SARS coronavirus nucleocapsid protein – Forms and functions
por: Chang, Chung-ke, et al.
Publicado: (2014)